Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Return on Equity (2021 - 2025)

Biofrontera has reported Return on Equity over the past 5 years, most recently at 0.03% for Q4 2025.

  • For Q4 2025, Return on Equity rose 1.0% year-over-year to 0.03%; the TTM value through Dec 2025 reached 0.03%, up 1.0%, while the annual FY2025 figure was 0.01%, 2.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.03% at Biofrontera, down from 0.05% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.74% in Q1 2024 and troughed at 0.22% in Q2 2021.
  • A 5-year average of 0.02% and a median of 0.02% in 2024 define the central range for Return on Equity.
  • Biggest five-year swings in Return on Equity: skyrocketed 75bps in 2024 and later crashed -79bps in 2025.
  • Year by year, Return on Equity stood at 0.12% in 2021, then plummeted by -100bps to 0.0% in 2022, then plummeted by -24969bps to 0.07% in 2023, then skyrocketed by 48bps to 0.04% in 2024, then rose by 25bps to 0.03% in 2025.
  • Business Quant data shows Return on Equity for BFRI at 0.03% in Q4 2025, 0.05% in Q3 2025, and 0.08% in Q2 2025.